Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-10-12

Clinical Trial Update: Feasibility Study of Cavity Radiofrequency Ablation in ex Vivo Mastectomy Breast Tissue [NA]

View source ↗

Summary

A feasibility study on cavity radiofrequency ablation in ex vivo mastectomy breast tissue has been withdrawn by the sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Arkansas | Conditions: Breast Cancer | NA | Status: WITHDRAWN